Despite many obstacles, Dimerix is getting to the pointy end of things with its kidney drug trial program. ...
Vous n'êtes pas connecté
Despite many obstacles, Dimerix is getting to the pointy end of things with its kidney drug trial program. ...
Despite many obstacles, Dimerix is getting to the pointy end of things with its kidney drug trial program. ...
Dimerix has enrolled the first patient into the Open Label Extension study for its kidney disease drug candidate DMX-200 after ...
Clinical-stage biotech Dimerix has achieved a key milestone with the first paediatric site opening for its ACTION3 Phase 3 clinical ...
Clinical-stage biotech Dimerix has achieved a key milestone with the first paediatric site opening for its ACTION3 Phase 3 clinical ...
Blinklab expects rapid US approval for its phone-based autism test that can detect the condition within minutes. ...
By Rebecca Gordon Washington Postheadlinereads: “A big problem for young workers: 70- and 80-year-olds who won’t retire.” For the first time...
Drug company Indies Pharma Jamaica Limited is looking to double next year’s revenues, following approval of its abbreviated new drug application,...
SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...
SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration...